CAS 1933507-63-1

4-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamide

CAS: 1933507-63-1

4-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamide

Formel: C₃₆H₅₈N₂O₅S

Reinheit: 96%

Molekulargewicht: 630.92

Ref: 54-OR1112331

4-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamide

CAS: 1933507-63-1

Reinheit: 96%

Ref: IN-DA020KNA

EDP-305

CAS: 1933507-63-1

EDP-305 is a potent and selective inhibitor of kinases that are involved in tumor growth and progression. This medicinal compound has shown promising results as an anticancer agent in preclinical studies. EDP-305 has been found to induce apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of specific kinases. The compound has also been shown to inhibit the proliferation of cancer cells and reduce tumor growth in animal models. EDP-305 is an analog of a Chinese herbal medicine that has been used traditionally for its anticancer properties. This protein inhibitor is excreted through urine and may have potential as a therapeutic agent for various types of cancer.

Formel: C₃₆H₅₈N₂O₅S

Reinheit: Min. 95%

Molekulargewicht: 630.9 g/mol

Ref: 3D-ICD50763

EDP-305

CAS: 1933507-63-1

EDP-305 is an oral non-bile acid FXR agonist for NAFLD and fibrosis research.

Formel: C₃₆H₅₈N₂O₅S

Reinheit: 97.17%

Farbe und Form: Solid

Molekulargewicht: 630.92

Ref: TM-T73414